肿瘤常见并发症——上腔静脉综合征的临床处理

2017-10-24 Ryy 肿瘤资讯

什么是上腔静脉综合征?上腔静脉综合征(superior vein cave syndrome, SVCS)是由于上腔静脉回流到右心房的血流部分或完全受阻而导致的一系列临床综合征。根据起病的缓急、梗阻的部位、阻塞的程度及是否建立有效的侧枝循环等情况表现为肿瘤急症或亚急症。解剖位置及病理生理上腔静脉位于右侧第一胸肋关节后方,由左右头臂静脉汇合而成,注入右心房。上腔静脉负责收集头颈、上肢、胸壁及部分胸腔

什么是上腔静脉综合征?上腔静脉综合征(superior vein cave syndrome, SVCS)是由于上腔静脉回流到右心房的血流部分或完全受阻而导致的一系列临床综合征。根据起病的缓急、梗阻的部位、阻塞的程度及是否建立有效的侧枝循环等情况表现为肿瘤急症或亚急症。

解剖位置及病理生理

上腔静脉位于右侧第一胸肋关节后方,由左右头臂静脉汇合而成,注入右心房。上腔静脉负责收集头颈、上肢、胸壁及部分胸腔脏器静脉血流,回流膈以上上半身的静脉血。上腔静脉紧邻右主支气管和升主动脉,在其与奇静脉吻合处,四周为淋巴结所包绕;整个右侧胸腔和左下胸腔的淋巴液流经以上淋巴结。

临床表现

根据其解剖部位一旦上腔静脉受压或梗阻导致回流不充分,会出现以下症状:

1)颜面、颈部、双上肢及躯干水肿。

2)颈静脉充盈,侧枝循环建立时可见特征性胸壁浅静脉怒张、皮肤发绀。

3)喉部、气管与支气管水肿引起咳嗽,呼吸困难、声嘶和喘鸣,平卧或屈曲时症状加剧。

4)咽部水肿,吞咽困难。

5)眶周水肿,结膜充血,可伴有眼球突出。

6)脑水肿与颅内高压,引起头痛、眩晕、惊厥及视觉与意识障碍。

7)周围静脉压升高,双上肢静脉压高于下肢,肘前静脉压常升至30--50cmH2O。

8)继发颅内压升高可并发脑水肿,典型表现为头痛、球结膜水肿、喷射性呕吐、意识障碍等。

诊断方法

结合病史、临床表现及影像学检查。影像学检查方法包括:

1.X线检查
X线透视及平片可发现上纵隔、右肺上叶、上腔静脉周围有占位影,上腔静脉受到肿块压迫。

2.多普勒超声
了解上腔静脉通畅程度,血栓/癌栓的范围,是否同时存在其他血管病变及外压性病变。

3.CT及磁共振
目前临床最常用检查方法,显示上腔静脉受阻的具体部位及侧支循环情况,可清楚显示胸内结构,明确病因。

4.上腔静脉造影
属有创性操作,通过两侧肘静脉或股静脉穿刺置管,可显示梗阻的部位,及远心端、近心端情况,可测量上腔静脉压力。并发症多风险较大,临床并不常用。

临床实践中以病因诊断为主,病因的明确有利于治疗决策。

治疗措施

SCVS是一种危及生命的肿瘤内科急症,应尽快取得组织学诊断,首先对症治疗缓解症状。

1 一般治疗 
患者头高脚低位,促进静脉回流降低静脉压,以减轻头面部及上半身水肿。吸氧可以缓解憋气症状。限制水钠入量以减少循环血量。应用速尿、甘露醇等利尿治疗减轻水肿。激素可以抑制炎症反应减轻压迫症状,对缓解咽喉水肿及脑水肿有效。癌症患者高凝状态可以适当抗凝治疗。

2 放疗
凡遇并发脑水肿、心排出量减少或呼吸道水肿等急症状况时,放疗为首选治疗方式。特别是非小细胞肺癌,放射治疗是主要的治疗方法,放射剂量取决于原发肿瘤的病理类型及分期。

3 化疗
对于小细胞肺癌、恶性淋巴瘤及生殖细胞肿瘤,化疗较为敏感。足量化疗可以有效控制全身播散,然后对局部病灶行放射治疗,以减少复发。目前认为SCVS选择联合化疗和放疗是标准的治疗模式。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1697556, encodeId=e084169e5566a, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Fri Aug 10 04:09:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036298, encodeId=050e2036298f1, content=<a href='/topic/show?id=c4a922e580d' target=_blank style='color:#2F92EE;'>#临床处理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22758, encryptionId=c4a922e580d, topicName=临床处理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Tue Aug 21 09:09:00 CST 2018, time=2018-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757870, encodeId=60ec1e57870d8, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sat Apr 28 21:09:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2027820, encodeId=3956202e820a1, content=<a href='/topic/show?id=e3442005ee4' target=_blank style='color:#2F92EE;'>#上腔静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20057, encryptionId=e3442005ee4, topicName=上腔静脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d1e370, createdName=yibei, createdTime=Fri May 11 14:09:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941122, encodeId=ad701941122a4, content=<a href='/topic/show?id=769720059c5' target=_blank style='color:#2F92EE;'>#上腔静脉综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20059, encryptionId=769720059c5, topicName=上腔静脉综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28b7142, createdName=liuquan, createdTime=Tue Apr 17 02:09:00 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430990, encodeId=251e14309903d, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Oct 26 13:09:00 CST 2017, time=2017-10-26, status=1, ipAttribution=)]
    2018-08-10 fusion
  2. [GetPortalCommentsPageByObjectIdResponse(id=1697556, encodeId=e084169e5566a, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Fri Aug 10 04:09:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036298, encodeId=050e2036298f1, content=<a href='/topic/show?id=c4a922e580d' target=_blank style='color:#2F92EE;'>#临床处理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22758, encryptionId=c4a922e580d, topicName=临床处理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Tue Aug 21 09:09:00 CST 2018, time=2018-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757870, encodeId=60ec1e57870d8, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sat Apr 28 21:09:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2027820, encodeId=3956202e820a1, content=<a href='/topic/show?id=e3442005ee4' target=_blank style='color:#2F92EE;'>#上腔静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20057, encryptionId=e3442005ee4, topicName=上腔静脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d1e370, createdName=yibei, createdTime=Fri May 11 14:09:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941122, encodeId=ad701941122a4, content=<a href='/topic/show?id=769720059c5' target=_blank style='color:#2F92EE;'>#上腔静脉综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20059, encryptionId=769720059c5, topicName=上腔静脉综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28b7142, createdName=liuquan, createdTime=Tue Apr 17 02:09:00 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430990, encodeId=251e14309903d, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Oct 26 13:09:00 CST 2017, time=2017-10-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1697556, encodeId=e084169e5566a, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Fri Aug 10 04:09:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036298, encodeId=050e2036298f1, content=<a href='/topic/show?id=c4a922e580d' target=_blank style='color:#2F92EE;'>#临床处理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22758, encryptionId=c4a922e580d, topicName=临床处理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Tue Aug 21 09:09:00 CST 2018, time=2018-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757870, encodeId=60ec1e57870d8, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sat Apr 28 21:09:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2027820, encodeId=3956202e820a1, content=<a href='/topic/show?id=e3442005ee4' target=_blank style='color:#2F92EE;'>#上腔静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20057, encryptionId=e3442005ee4, topicName=上腔静脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d1e370, createdName=yibei, createdTime=Fri May 11 14:09:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941122, encodeId=ad701941122a4, content=<a href='/topic/show?id=769720059c5' target=_blank style='color:#2F92EE;'>#上腔静脉综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20059, encryptionId=769720059c5, topicName=上腔静脉综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28b7142, createdName=liuquan, createdTime=Tue Apr 17 02:09:00 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430990, encodeId=251e14309903d, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Oct 26 13:09:00 CST 2017, time=2017-10-26, status=1, ipAttribution=)]
    2018-04-28 丁鹏鹏
  4. [GetPortalCommentsPageByObjectIdResponse(id=1697556, encodeId=e084169e5566a, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Fri Aug 10 04:09:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036298, encodeId=050e2036298f1, content=<a href='/topic/show?id=c4a922e580d' target=_blank style='color:#2F92EE;'>#临床处理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22758, encryptionId=c4a922e580d, topicName=临床处理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Tue Aug 21 09:09:00 CST 2018, time=2018-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757870, encodeId=60ec1e57870d8, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sat Apr 28 21:09:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2027820, encodeId=3956202e820a1, content=<a href='/topic/show?id=e3442005ee4' target=_blank style='color:#2F92EE;'>#上腔静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20057, encryptionId=e3442005ee4, topicName=上腔静脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d1e370, createdName=yibei, createdTime=Fri May 11 14:09:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941122, encodeId=ad701941122a4, content=<a href='/topic/show?id=769720059c5' target=_blank style='color:#2F92EE;'>#上腔静脉综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20059, encryptionId=769720059c5, topicName=上腔静脉综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28b7142, createdName=liuquan, createdTime=Tue Apr 17 02:09:00 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430990, encodeId=251e14309903d, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Oct 26 13:09:00 CST 2017, time=2017-10-26, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1697556, encodeId=e084169e5566a, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Fri Aug 10 04:09:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036298, encodeId=050e2036298f1, content=<a href='/topic/show?id=c4a922e580d' target=_blank style='color:#2F92EE;'>#临床处理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22758, encryptionId=c4a922e580d, topicName=临床处理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Tue Aug 21 09:09:00 CST 2018, time=2018-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757870, encodeId=60ec1e57870d8, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sat Apr 28 21:09:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2027820, encodeId=3956202e820a1, content=<a href='/topic/show?id=e3442005ee4' target=_blank style='color:#2F92EE;'>#上腔静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20057, encryptionId=e3442005ee4, topicName=上腔静脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d1e370, createdName=yibei, createdTime=Fri May 11 14:09:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941122, encodeId=ad701941122a4, content=<a href='/topic/show?id=769720059c5' target=_blank style='color:#2F92EE;'>#上腔静脉综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20059, encryptionId=769720059c5, topicName=上腔静脉综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28b7142, createdName=liuquan, createdTime=Tue Apr 17 02:09:00 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430990, encodeId=251e14309903d, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Oct 26 13:09:00 CST 2017, time=2017-10-26, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1697556, encodeId=e084169e5566a, content=<a href='/topic/show?id=f2399910109' target=_blank style='color:#2F92EE;'>#静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99101, encryptionId=f2399910109, topicName=静脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bc129907796, createdName=fusion, createdTime=Fri Aug 10 04:09:00 CST 2018, time=2018-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036298, encodeId=050e2036298f1, content=<a href='/topic/show?id=c4a922e580d' target=_blank style='color:#2F92EE;'>#临床处理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22758, encryptionId=c4a922e580d, topicName=临床处理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e093393, createdName=luwei00, createdTime=Tue Aug 21 09:09:00 CST 2018, time=2018-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1757870, encodeId=60ec1e57870d8, content=<a href='/topic/show?id=84ba49031f9' target=_blank style='color:#2F92EE;'>#并发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49031, encryptionId=84ba49031f9, topicName=并发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a27e37327108, createdName=丁鹏鹏, createdTime=Sat Apr 28 21:09:00 CST 2018, time=2018-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2027820, encodeId=3956202e820a1, content=<a href='/topic/show?id=e3442005ee4' target=_blank style='color:#2F92EE;'>#上腔静脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20057, encryptionId=e3442005ee4, topicName=上腔静脉)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3d1e370, createdName=yibei, createdTime=Fri May 11 14:09:00 CST 2018, time=2018-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1941122, encodeId=ad701941122a4, content=<a href='/topic/show?id=769720059c5' target=_blank style='color:#2F92EE;'>#上腔静脉综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20059, encryptionId=769720059c5, topicName=上腔静脉综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=28b7142, createdName=liuquan, createdTime=Tue Apr 17 02:09:00 CST 2018, time=2018-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430990, encodeId=251e14309903d, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Oct 26 13:09:00 CST 2017, time=2017-10-26, status=1, ipAttribution=)]

相关资讯

Cell Metab:研究揭示肥胖是如何一步步诱发了乳腺癌!

肥胖导致细胞因子释放到影响乳腺癌细胞代谢的血液中,从而使它们更具侵略性。来自亥姆霍兹中心慕尼黑,慕尼黑工业大学(TUM)和海德堡大学医院的科学家在细胞代谢中报道了这一点。该小组已经能够通过抗体治疗来阻止这种机制。

Cell:跨界达人卢冠达解决困扰免疫治疗的两大难题

为了生存,癌细胞似乎动用了一切手段和办法。日前,发表在Science杂志上的一篇新论文中,来自哈佛医学院的科学家们证实,一种被称为“氨”的细胞代谢废弃副产物能够被癌细胞巧妙地重新利用,帮助其生长。研究者们认为,这项成果有望帮助设计新的抗癌疗法。

Int J Oral Max Surg:鼻假体对于美学和功能的修复

目的是评估患者根治性肿瘤切除后鼻假体对于美学和功能的修复。

良好情绪有助于肿瘤治疗

“与传统的临床治疗相比,功能医学更关心病人的饮食、营养、睡眠、运动、压力、人际关系、遗传等等,希望用更自然的疗法促进健康。”“肿瘤属于慢性疾病,而任何慢性病在发生之前,都有体内功能慢性下降的过程,这个慢慢下降的过程,最终导致的是终端疾病的发生。”武警北京总队医院胸部肿瘤微创治疗中心副主任左占杰。武警北京总队医院胸部肿瘤微创治疗中心副主任左占杰。北京中西医慢性病防治学会健康评估与疾病干预全国委员

Nat Commun:大数据揭开肿瘤向周围传播扩散的“秘密”!

加州旧金山的研究人员结合起源似乎不兼容的数据,分析了八种最常见癌症中肿瘤相邻组织中的分子特征,表明它们都使用相同的机制来改造正常组织并传播。

生死一刻,医患并肩战斗!

医和患到底是什么关系?透过这起病例,我相信无论在朱玉萍医生的心中,还是在患者一家人的心中,经过生死洗礼之后都会有说不出的美好和美妙。而这美好和美妙的背后是爱。生死面前,最难的往往不是技术。唯有爱,才能让医患走得更远!唯有爱,才能让医患共赢!